FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Squill opiate linctus paediatric VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 500micrograms/5ml solution for injection pre-filled syringes VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Argatroban 250mg/2.5ml solution for infusion vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Exembol 250mg/2.5ml concentrate for solution for infusion vials (Mitsubishi Pharma Europe Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Exembol 250mg/2.5ml concentrate for solution for infusion vials (Mitsubishi Pharma Europe Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Sovereign Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Sovereign Medical Ltd) 90 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 120mg/5ml / Diphenhydramine 12.5mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Medised Infant oral solution (SSL International Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 120mg/5ml / Diphenhydramine 12.5mg/5ml oral solution 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dozol liquid (Manx Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Paracetamol 120mg/5ml / Diphenhydramine 12.5mg/5ml oral solution 200 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calpol Night oral solution (Pfizer Consumer Healthcare) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
CalCold oral solution (Pfizer Consumer Healthcare) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Medised Infant oral solution (SSL International Plc) 200 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
CalCold oral solution (Pfizer Consumer Healthcare) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Medised Infant oral solution (SSL International Plc) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calpol Night oral solution (Pfizer Consumer Healthcare) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Dozol liquid (Manx Healthcare Ltd) 100 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
KerraFoam Simple Border dressing 15cm x 20cm (Crawford Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
KerraFoam Simple Border dressing 15cm x 20cm (Crawford Healthcare Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
KerraFoam Simple Border dressing 15cm x 20cm (Crawford Healthcare Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (Consilient Health Ltd) 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (Kent Pharma (UK) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles 5 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (Consilient Health Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (A A H Pharmaceuticals Ltd) 5 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (Consilient Health Ltd) 5 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 100mg/50ml solution for infusion bottles (Kent Pharma (UK) Ltd) 5 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chlorhexidine gluconate 5% solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
High Purity Factor VIII 250unit powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Idarubicin 10mg/10ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 200mg/100ml infusion bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Clomethiazole 157.5mg/5ml oral solution sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hydroxyzine 10mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 5mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 50mg/0.5ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 50mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Levofloxacin 500mg/100ml solution for infusion vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 10mmol/500ml) / Glucose 5% infusion 500ml bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Idarubicin 5mg/5ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium hyaluronate 8.5mg/0.85ml solution for injection pre-filled syringes VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Doxapram 100mg/5ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium fusidate 500mg powder and solvent for solution for infusion vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hexetidine 0.1% mouthwash sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Guanethidine 10mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 30mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/5ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 100mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nalbuphine 20mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tenoxicam 20mg powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Propofol 500mg/50ml emulsion for infusion vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulfate 68mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metaraminol 10mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tramadol 75mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Hypromellose 0.32% eye drops 0.5ml unit dose preservative free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Phentolamine 10mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 25,000units/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 5,000units/0.2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 50mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Gentamicin 20mg/2ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Clotrimazole 1% powder VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Propofol 1g/100ml emulsion for infusion vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin sodium 1,000units/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Heparin calcium 5,000units/0.2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Procyclidine 10mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Propofol 1g/50ml emulsion for infusion vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fluphenazine decanoate 25mg/1ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone propionate 100mg/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Naloxone 40micrograms/2ml solution for injection ampoules VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 10mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nisoldipine 20mg modified-release tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pericyazine 10mg/5ml oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetylcysteine 10% eye drops preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Argatroban 250mg/2.5ml solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levobupivacaine 250mg/200ml infusion bags VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arachis oil 130ml enema VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ascorbic acid 500mg/5ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 500micrograms/5ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tenoxicam 20mg powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 80 of 86 Next End


This concept is not in any reference sets

Back to Start